Impact of Treatment with Inotuzumab Ozogamicin before or after Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed/Refractory Acute Lymphoblastic Leukemia

被引：2
|
作者：
Rheingold, Susan R. [1 ]
Ji, Lingyun [2 ]
Gore, Lia [3 ]
Xu, Xinxin [4 ]
Bhojwani, Deepa [5 ]
Shah, Nirali N. [6 ]
Raetz, Elizabeth A. [7 ]
Loh, Mignon L. [8 ]
O'Brien, Maureen M. [9 ]
机构：
[1] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA USA
[2] Univ Southern Calif, Dept Populat & Publ Hlth Sci, Los Angeles, CA USA
[3] Univ Colorado, Ctr Canc, Ctr Canc & Blood Disorders, Aurora, CO USA
[4] Childrens Oncol Grp, Monrovia, CA USA
[5] Childrens Hosp Los Angeles, Hematol Oncol, Los Angeles, CA USA
[6] NIH, Pediat Oncol Branch, Bethesda, MD USA
[7] NYU Langone Hlth, Dept Pediat, New York, NY USA
[8] Seattle Childrens Hosp, Ben Towne Ctr Childhood Canc Res, Seattle, WA USA
[9] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-183103
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Potential Impact of Treatment with Inotuzumab Ozogamicin on Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia
    Ceolin, Valeria
    Brivio, Erica
    Rheingold, Susan R.
    Leahy, Allison Barz
    Vormoor, Britta Julia
    O'Brien, Maureen M.
    Rubinstein, Jeremy
    Kalwak, Krzysztof
    De Moerloose, Barbara
    Jacoby, Elad
    Bader, Peter
    Fuster, Jose L.
    Locatelli, Franco
    Hoogerbrugge, Peter
    Calkoen, Friso
    Zwaan, Christian M.
    BLOOD, 2021, 138 : 3824 - +
  • [2] Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia
    Valeria Ceolin
    Erica Brivio
    Harm van Tinteren
    Susan R. Rheingold
    Allison Leahy
    Britta Vormoor
    Maureen M. O’Brien
    Jeremy D. Rubinstein
    Krzysztof Kalwak
    Barbara De Moerloose
    Elad Jacoby
    Peter Bader
    Mónica López-Duarte
    Bianca F. Goemans
    Franco Locatelli
    Peter Hoogerbrugge
    Friso G. Calkoen
    Christian Michel Zwaan
    Leukemia, 2023, 37 : 53 - 60
  • [3] Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia
    Ceolin, Valeria
    Brivio, Erica
    van Tinteren, Harm
    Rheingold, Susan R.
    Leahy, Allison
    Vormoor, Britta
    O'Brien, Maureen M.
    Rubinstein, Jeremy D.
    Kalwak, Krzysztof
    De Moerloose, Barbara
    Jacoby, Elad
    Bader, Peter
    Lopez-Duarte, Monica
    Goemans, Bianca F.
    Locatelli, Franco
    Hoogerbrugge, Peter
    Calkoen, Friso G.
    Zwaan, Christian Michel
    LEUKEMIA, 2023, 37 (01) : 53 - 60
  • [4] Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia
    Uy, Natalie
    Nadeau, Michelle
    Stahl, Maximilian
    Zeidan, Amer M.
    JOURNAL OF BLOOD MEDICINE, 2018, 9 : 67 - 74
  • [5] Role of inotuzumab ozogamicin in the treatment of relapsed/refractory acute lymphoblastic leukemia
    George, Binsah
    Kantarjian, Hagop
    Jabbour, Elias
    Jain, Nitin
    IMMUNOTHERAPY, 2016, 8 (02) : 135 - 143
  • [6] OBSERVATIONAL STUDY OF CHILDREN REQUIRING CRITICAL CARE AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY FOR REFRACTORY/ RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA
    Ramanathan, G.
    Gupta, C.
    Bonney, D.
    PEDIATRIC CRITICAL CARE MEDICINE, 2022, 23 (11)
  • [7] Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia
    Marks, David, I
    Kebriaei, Partow
    Stelljes, Matthias
    Goekbuget, Nicola
    Kantarjian, Hagop
    Advani, Anjali S.
    Merchant, Akil
    Stock, Wendy
    Cassaday, Ryan D.
    Wang, Tao
    Zhang, Hui
    Loberiza, Fausto
    Vandendries, Erik
    DeAngelo, Daniel J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (09) : 1720 - 1729
  • [8] Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia
    Oh, Bernice L. Z.
    Vinanica, Natasha
    Wong, Desmond M. H.
    Campana, Dario
    HAEMATOLOGICA, 2024, 109 (06) : 1677 - 1688
  • [9] Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
    Bhojwani, Deepa
    Sposto, Richard
    Shah, Nirali N.
    Rodriguez, Vilmarie
    Yuan, Constance
    Stetler-Stevenson, Maryalice
    O'Brien, Maureen M.
    McNeer, Jennifer L.
    Quereshi, Amrana
    Cabannes, Aurelie
    Schlegel, Paul
    Rossig, Claudia
    Dalla-Pozza, Luciano
    August, Keith
    Alexander, Sarah
    Bourquin, Jean-Pierre
    Zwaan, Michel
    Raetz, Elizabeth A.
    Loh, Mignon L.
    Rheingold, Susan R.
    LEUKEMIA, 2019, 33 (04) : 884 - 892
  • [10] Cost-effectiveness of chimeric antigen receptor T-cell therapy in pediatric relapsed/refractory acute lymphoblastic leukemia.
    Sarkar, Reith
    Gloude, Nicholas Joseph
    Murphy, James Don
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345